[go: up one dir, main page]

SK281803B6 - Oral enteric-coated preparation containing the magnesium salt of omeprazole and method for its production - Google Patents

Oral enteric-coated preparation containing the magnesium salt of omeprazole and method for its production

Info

Publication number
SK281803B6
SK281803B6 SK1660-96A SK166096A SK281803B6 SK 281803 B6 SK281803 B6 SK 281803B6 SK 166096 A SK166096 A SK 166096A SK 281803 B6 SK281803 B6 SK 281803B6
Authority
SK
Slovakia
Prior art keywords
omeprazole
nuclear material
production
magnesium salt
preparation containing
Prior art date
Application number
SK1660-96A
Other languages
Slovak (sk)
Other versions
SK166096A3 (en
Inventor
Siv Inga Bengtsson
Kurt Ingmar LÖVGREN
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK166096A3 publication Critical patent/SK166096A3/en
Publication of SK281803B6 publication Critical patent/SK281803B6/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oral enterically coated preparation contains nuclear material of effective component coated with one or more enterical coating layers. Nuclear material as the effective component contains omeprasol magnesian salt with the crystallinity degree higher than 70 %, rated by RTG powdery difraction, and on the nuclear material enterical coating layer(s) which make from 1.0 % of wt. of weight of nuclear material, and method for its preparation.
SK1660-96A 1994-07-08 1995-07-03 Oral enteric-coated preparation containing the magnesium salt of omeprazole and method for its production SK281803B6 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31320894A 1994-07-08 1994-07-08
SE9400679 1994-07-08
PCT/SE1995/000816 WO1996001622A1 (en) 1994-07-08 1995-07-03 New oral pharmaceutical formulation containing magnesium salt of omeprazole

Publications (2)

Publication Number Publication Date
SK166096A3 SK166096A3 (en) 1997-09-10
SK281803B6 true SK281803B6 (en) 2001-08-06

Family

ID=20393105

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1660-96A SK281803B6 (en) 1994-07-08 1995-07-03 Oral enteric-coated preparation containing the magnesium salt of omeprazole and method for its production

Country Status (15)

Country Link
EP (1) EP0768872A1 (en)
KR (1) KR970704426A (en)
BR (1) BR9508261A (en)
CA (1) CA2193681A1 (en)
CZ (1) CZ379596A3 (en)
EE (1) EE03378B1 (en)
FI (1) FI970058A0 (en)
HU (1) HUT78132A (en)
IS (1) IS4398A (en)
MX (1) MX9700152A (en)
NO (1) NO970036D0 (en)
NZ (1) NZ289958A (en)
PL (1) PL181265B1 (en)
SK (1) SK281803B6 (en)
WO (1) WO1996001622A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500478D0 (en) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5900258A (en) * 1996-02-01 1999-05-04 Zeolitics Inc. Anti-bacterial compositions
SI9700186B (en) 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Novel pharmaceutical preparation with controlled release of active healing substances
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9704870D0 (en) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
SE9704869D0 (en) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9802973D0 (en) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6316020B1 (en) * 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
EP1133987A1 (en) * 2000-03-09 2001-09-19 Ian Whitcroft Treatment of inflammatory dermatoses with combinations of erythromycin or clarythromycin, metronidazole and a hydrogen pump inhibitor
EP1263445A1 (en) * 2000-03-09 2002-12-11 Ian Whitcroft Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin, metronidazole and a gastrointestinal hydrogen pump inhibitor
AU2003273000A1 (en) 2002-10-16 2004-05-04 Takeda Pharmaceutical Company Limited Stable solid preparations
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2570796A1 (en) * 2004-06-15 2006-01-05 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical formulations of benzimidazole compounds
CN105106168B (en) * 2015-08-19 2018-03-06 德州德药制药有限公司 A kind of esomeprazole magnesium intestines capsule and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JPH0768125B2 (en) * 1988-05-18 1995-07-26 エーザイ株式会社 Oral formulation of acid labile compounds
SE9302396D0 (en) * 1993-07-09 1993-07-09 Ab Astra A NOVEL COMPOUND FORM
SE9302395D0 (en) * 1993-07-09 1993-07-09 Ab Astra NEW PHARMACEUTICAL FORMULATION

Also Published As

Publication number Publication date
WO1996001622A1 (en) 1996-01-25
AU2994795A (en) 1996-02-09
WO1996001622A8 (en) 1999-12-23
FI970058L (en) 1997-01-07
NO970036L (en) 1997-01-06
NO970036D0 (en) 1997-01-06
SK166096A3 (en) 1997-09-10
KR970704426A (en) 1997-09-06
BR9508261A (en) 1997-12-23
PL318464A1 (en) 1997-06-09
MX9700152A (en) 1997-04-30
CZ379596A3 (en) 1997-08-13
CA2193681A1 (en) 1996-01-25
HU9700039D0 (en) 1997-02-28
AU695723B2 (en) 1998-08-20
IS4398A (en) 1996-12-17
EE03378B1 (en) 2001-04-16
FI970058A7 (en) 1997-01-07
FI970058A0 (en) 1997-01-07
EE9700014A (en) 1997-06-16
NZ289958A (en) 1998-09-24
EP0768872A1 (en) 1997-04-23
PL181265B1 (en) 2001-06-29
HUT78132A (en) 2000-06-28

Similar Documents

Publication Publication Date Title
SK281803B6 (en) Oral enteric-coated preparation containing the magnesium salt of omeprazole and method for its production
FI921156A7 (en) Intumescent refractory coating, refractory material and method for producing refractory material
DE3874836D1 (en) THERMALIZING POWDERED COATING COMPOSITION.
GR3024043T3 (en) Antifouling coating composition.
DE59203191D1 (en) Component set for the production of packaging.
CA2224996A1 (en) Water swellable compositions
AU8119687A (en) Multiple-layer, cook-in film
DE69112081D1 (en) THERMALIZING COATING COMPOSITIONS WITH IMPROVED HARDNESS.
FI875153A7 (en) A method for controlling and/or measuring the thickness of layers, such as surface layers on substrates.
CA2054257A1 (en) A method of providing anti-oxidation protection for a composite material containing carbon, and a material protected thereby
MX9203168A (en) SUBSTRATE PROVIDED WITH MULTIPLE LAYERS, PROCEDURE FOR THE FORMATION OF SUCH LAYERS AND COATING COMPOSITION.
IT8420664A0 (en) PROCEDURE FOR PREPARING A FINELY DIVIDED POWDER SELECTED FROM THE GROUP CONSISTING OF TITANIUM DIBOride POWDER AND ZIRCONIUM DIBOride POWDER.
AU6333299A (en) High luster, flexible multilayered film with a polyamide outer layer containing nanodispersed filling material and utilization of said film for packaging foodstuffs
GR3015104T3 (en) Antifouling coating compositions.
FI99205B (en) Cocatalytic preparation useful polymerization of olefins, catalytic system, this containing catalytic system and polymerization process
MX9204272A (en) COMPOSITIONS FOR THERMOSTABLE POWDER COATINGS.
FI943082A7 (en) Isophorone-free coating composition containing fluorocarbon
AU7702691A (en) Polysiloxane coating composition
NO944612L (en) Fire resistant material, especially for cable coating
UA37254C2 (en) Multi-layered paper
JPS5316735A (en) Manufacture of fireproof coating compounds
JPS5388082A (en) Fluororesin-coated article
JPS527587A (en) Ship stern tube seal liner
JPS5240541A (en) Sheet or tape for wrapping or equipment
JPS52119645A (en) Fireproof tape